Piramal Pharma Ltd receives US FDA Form 483 with four observations at its Lexington facility, plans detailed response and ...

NEWS RELEASE: ten23 health QC lab to support commercial product testing for U.S. customer following FDA approvals Basel, Switzerland — ten23 health, the ten23 health says its Basel and Visp QC ...

Dr Reddy's Laboratories receives US FDA Form 483 with five observations at Srikakulam facility; company to address issues ...

Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...

Diamyd Medical's registrational Phase 3 trial in type 1 diabetes, has now exceeded 290, and the screening will conclude in the coming weeks. The interim ...

The CNPV pilot program approved its first drug, an amoxicillin-clavulanate potassium antibiotic, in two months, enhancing domestic manufacturing and national security. Augmentin XR, combining ...

A blood pressure drug was recalled over possible contamination.

US FDA fortifies regulatory alliance with Telangana DCA in Hyderabad: Peethaambaran Kunnathoor, Chennai Monday, December 8, 2025, 08:00 Hrs [IST] A high-level delegation from the ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

A recent preemption decision out of the Southern District of New York offers encouraging news for medical device ...

Piramal Pharma's US facility inspection concluded with four observations from the FDA. The company expects a voluntary action ...